Cannabis Science Inc (fka CBIS)

[dangerx]

Think of the entire drug market as the OTC market, CBIS represents a pot stock in this market. This market is notoriously unregulated and very rarely do earnings get reported. At this very moment, pot is making a move to a more legitimate market. Once there (if ever) we will see earnings, business development and all the rest of the components of a real business. For now though, an American company focused on the cultivation, preparation, and distribution of cannabis based products would be wise to keep earnings and plans for future earnings on the down low